Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Peijie Pharmaceutical Research is a China-based pharmaceutical research and development company focused on the discovery and development of innovative small molecule drugs. The company operates primarily as a contract research organization (CRO) while also maintaining an internal pipeline of therapeutic candidates. Its research efforts span across several therapeutic areas, including infectious diseases, inflammatory conditions, and metabolic disorders. Peijie Pharmaceutical Research provides comprehensive R&D services ranging from medicinal chemistry and lead optimization to pre-clinical evaluation. The company aims to bridge the gap between early-stage laboratory discovery and clinical application through its integrated research platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Peijie Pharmaceutical Research.